Professional Organizations, Evolution of Pharmacy in India Introduction: The Evolution of Pharmacy in India

1.1Ancient Roots and Cultural Foundations

The history of pharmacy in India is inextricably woven into the fabric of the country’s ancient civilizations. Archaeological and historical records show that India was home to some of the earliest systems of healthcare and medicinal knowledge. Redolent with a wealth of tradition, the Vedic period (c. 1500–500 BCE) introduced holistic practices where medical treatment was based on harmony between mind, body, and spirit.

The Atharva Veda, one of India’s oldest scriptures, contains references to the medicinal properties of hundreds of herbs and minerals, reflecting a proto-pharmacy tradition deeply entwined with religious and philosophical beliefs. Ayurveda, considered the “science of life,” emerged as a sophisticated system for diagnosing, preparing, and dispensing drugs. Ayurvedic texts such as the Charaka Samhita and Sushruta Samhita detail elaborate methods for the collection, purification, processing, and compounding of plant, animal, and mineral substances.

These texts, compiled between 600 BCE and 200 CE, not only cataloged over a thousand medicinal plants but also established protocols for formulation and dosages, emphasizing preventive healthcare and personalized treatment. Simultaneously, othe r traditional systems like Siddha (prevalent in southern India) and Unani (introduced by Arab and Persian influences) enriched India’s medical and pharmaceutical knowledge. Notably, practitioners in these systems performed multiple roles— they diagnosed illnesses, prepared medicines, and dispensed remedies, demonstrating a holistic integration of pharmacy and medical practice.

Empirical in nature, these traditions were passed down through generations orally or via apprenticeships, and they continue to influe nce contemporary alternative medicine and pharmacognosy research. 1.2 The Colonial Influence: Transformation and Hybridization The arrival of European colonial powers, most significantly the British, marked a paradigm shift in healthcare practices in India . The British colonial administration established Western medical schools, dispensaries, and hospitals, initially intended for military forces and colonial officials but gradually expanded for the local population. This period saw the introduction of allopathic medicine and the segmentation of roles between prescribers (physicians) and dispensers (compounders or pharmacists) However, early compounders were often individuals with little formal training, and the preparation of drugs lacked standardization .

The gap between Western pharmaceutical knowledge and indigenous practices led to inconsistencies in drug safety, quality, and efficacy, posing significant risks to public health. These shortcomings underscored a pressing need for the institutionalization of pharmacy education and the regulation of pharmaceutical practice. During the late 19th and early 20th centuries, India began to witness the gradual establishment of pharmacy courses and colleges, inspired by curricula in Britain and Europe.

The influen ce of British pharmacopeia, coupled with government regulations, started to create a clearer demarcation between physicians and pharmacists. This period also saw the import and local manufacture of modern drugs, fertilizer, and chemicals, gradually diminis hing the dominance of traditional remedies in urban settings while encouraging the coexistence of indigenous and modern systems in rural areas.

1.3Professionalization and Regulatory Milestones

The early 20th century marked a pivotal phase for pharmacy in India. The First World War and subsequent global events underscored India’s dependence on imported medicines, exposing vulnerabilities that hindered public health. Advocates for indigenous industry and scientific advancement championed the cause for domestic pharmaceutical manufacturing and a professionally recognized cadre of pharmacists A watershed moment came with the Pharmacy Act of 1948, a piece of legislation passed by the newly independent Indian government.

This act established the Pharmacy Council of India (PCI)—the central standard -setting authority for pharmacy education, training, and professional registration. For the first time, pharmacy was officially recognized as a distinct healthcare profession, with statutory requirements for educational qualifications, curricula, and ethical standards. The Act’s implementation paved the way for the establishment of diploma, degree, and postgraduate programs in pharmacy across various universities and colleges nationwide.

Institutions began inves ting in research capacities, laboratories, and clinical training opportunities. This led to a new generation of Indian pharmacists with both theoretical knowledge and hands-on skills in compounding, dispensing, and counseling.

1.4Rise of the Pharmaceutical Industry

Parallel to educational reforms, the Indian pharmaceutical industry underwent rapid expansion. State-driven initiatives in the 1950s and 1960s focused on self -reliance, culminating in the creation of public sector undertakings and research organ izations such as the Central Drug Research Institute (CDRI), National Chemical Laboratory (NCL), and others. These efforts were further catalyzed by the Indian Patents Act of 1970, which granted process —but not product—patents, thereby enabling Indian firm s to reverse -engineer and manufacture affordable generic medicines.

Major Indian pharmaceutical companies—such as Cipla, Ranbaxy, Dr. Reddy’s, Sun Pharma, and others —emerged as global powerhouses for generic medication, antiretrovirals, and vaccines. Th e sector’s meteoric growth turned India into the so -called “Pharmacy of the World,” exporting life-saving drugs to more than 150 countries.

Quality control and regulatory compliance also advanced considerably. Establishment of bodies like the Central Drugs Standard Control Organization (CDSCO) at the national level and state drug control laboratories underscored India’s commitment to patient safety and international harmonization. India’s accession to global organizations such as the World Health Organization (WHO), and collaboration with agencies like the US FDA and EMA, enhanced international trust in Indian pharmaceuticals

1.5Diversification of Pharmacy Practice

Over the decades, the profession of pharmacy in India has diversified far beyond traditional compounding and dispensing. Modern pharmacists are now integral to multidisciplinary healthcare teams, contributing in areas such as:

• Clinical pharmacy: Participating in patient-centered care, medication therapy

management, and participation in ward rounds and pharmacovigilance

• Hospital pharmacy: Managing medication supply chains, sterile preparations, and

therapeutic drug monitoring

• Regulatory affairs: Overseeing compliance, documentation, product registration, and

policy-making

• Biotechnology and R&D: Innovating in drug discovery, formulation optimization, and

advanced therapies

• Academia: Driving research, curriculum development, and professional mentorship
• Community health: Educating the public about drug safety, rational use of medicine,

and preventive health Indian pharmacists are increasingly recognized for their clinical expertise, ethical responsibilities, and contributions to public health and global medicine access.

1.6Contemporary Challenges and Future Directions

Despite remarkable progres s, Indian pharmacy faces significant challenges. Regulatory fragmentation between central and state agencies sometimes hinders uniformity. Issues of counterfeit drugs, quality assurance lapses, and periodic shortages underscore the need for continuous vigilance and improvement.

Education quality, especially at private and unregulated institutions, has prompted calls for reforms to ensure that new professionals are competent, ethical, and globally competitive. Emerging trends in digital health, telepharma cy, personalized medicine, and artificial intelligence are redefining the pharmacist’s role in healthcare delivery. The need to align with international best practices is ongoing —India has joined global efforts (e.g., ICH membership in 2018) to harmonize s tandards and promote innovation in both education and industry. 2.

Evolution of Pharmacy in India The history of pharmacy in India is, at its core, the history of medicine itself —a journey spanning millennia, cultures, and ideological shifts. This chapt er delves into the intricate process by which pharmacy evolved from ancient holistic practices to a multifaceted healthcare profession, emphasizing how traditional systems shaped pharmaceutical thought and how colonial interventions redefined the landscape.

2.1Ancient and Traditional Systems of Medicine

The Vedic Foundations The roots of Indian medicinal practice can be traced to the Vedic period (circa 1500–800 BCE), a time when the synthesis of spiritual, philosophical, and empirical knowledge was at its zenith. The Rigveda, the oldest of India’s four Vedas, contains hundreds of hymns extolling the virtues of medicinal plants and natural remedies. Plants like Soma, Ashvagandha, Haritaki, and Amalaki, mentioned in hymns, remain pillars of pharmacognosy even today.

By the late Vedic period, India’s rich pantheon of flora and fauna had already lent itself to the treatment of common ailments —fever, wounds, digestive issues, and more. Practice was empirical, and documentation often encoded in metaphors or spiri tual allegories, ref lecting the era’s worldview. Ayurveda: Systematizing Pharmaceutical Knowledge Between 800 BCE and 500 CE, Ayurveda (“science of life”) emerged as a comprehensive codification of medical and pharmaceutical knowledge.

Ayurvedic texts such as the Charaka Samhita (focused on internal medicine) and the Sushruta Samhita (focused on surgery and surgical adjuncts) revolutionized notions of disease, health, and therapeutics Pharmaceutical Contributions of Ayurveda:

• Formulation Science: These works systematized the preparation and storage of

thousands of medicinal compounds —herbal decoctions (Kashayam), powders (Churnas), tablets (Vati/Gutika), clarified butter -based preparations (Ghritas), and medicated oils (Taila).

• Raw Materials: A wide range of botanicals (Triphala, Brahmi, Yashtimadhu), minerals

(Shilajit, Swarna Bhasma), and animal products (honey, milk, ghee) were referenced, with detailed chapters on purification and standardization.

• Dosage and Administration: Concepts like matra (dosage), anupana (adjuvant), and

tailored regimens were introduced, far ahead of their time in the global pharmacological context.

• Quality Assurance: The ancient texts prescribed seasonal guidelines for plant

harvesting and stressed the importance of enviro nment, patient constitution (prakriti), and pathology in drug selection Role and Status of the Vaidya The profession, however, remained undifferentiated regarding roles. The Vaidya acted as diagnostician, prescriber, pharmacist, and dispenser —a testam ent to the deeply integrated nature of traditional healthcare. Drug preparation was a sacred craft, guided by oral traditions and manuscripts, practiced in homes or small workshops attached to clinics.

Transmission of Knowledge Knowledge transmission was either through the guru-shishya tradition (teacher -disciple relationships) or in family lineages. Medical knowledge was often guarded, passed down as a mark of social and religious status, limiting widespread standardization. Mineral and Animal Materials Ayurveda and related systems did not restrict themselves to only plant materials.

For instance, metallic preparations (Bhasmas) and animal products (like sheep kidney or snake venom antitoxins) suggested an early understanding of the complex interactio ns between minerals/metals and biological systems.

2.2Influence of Siddha and Unani Medicine

Siddha System: Metallic Pharmacy and Southern Traditions The Siddha system emerged as a distinct medical tradition in the Tamil-speaking regions, likely around 6th century CE or earlier. Based on Tamil philosophical concepts and the doctrine of humors (mukkutram), the Siddha system built a corpus of medicine where minerals, metals, and plant products played a central role Key Pharmaceutical Innovations of Siddha:

• Rasaushadhis: The Siddhas pioneered the use of metals and minerals in medicine,

with advanced calcination techniques (Marana, Puti) transforming substances like gold, silver, mercury, and arsenic into bioavailable and (believed to be) non-toxic forms called Bhasmas

• Dosage Forms: Siddha contributed Churnam (fine

powders), Leham (confectionaries), Kashayam (decoctions), Mathirai (pills), and Parpam (ash formulations).

• Standardization Techniques: Rhythmic heating, purification (Shodhana), and repeated

grinding were used to ensure potency and safety. Most notably, Siddha pharmacy was deeply empirical and process -oriented; early texts like the Agathiyar Gunavagadam discussed the stabilization and toxicity reduction of mercury and arsenic—topics of modern pharmacology. Unani Medicine: Science, Art, and Process Unani medicine, introduced to India between the 11th and 13th centuries by Arab and Persian scholars, became especially prominent under the Mughal Empire.

Based on Greco -Arabic traditions (Galen, Hip pocrates, Ibn Sina/Avicenna), Unani placed a heavy emphasis on pharmacy as a science. Pharmaceutical Practices in Unani:

• Complex Compounding: Unani practitioners meticulously blended multiple

ingredients, employing processes like maceration (steeping in liquids), distillation, crystallization, triturating (grinding), and infusion.

• Dosage Forms: Common preparations

included Arka (distillates), Majoon (electuaries), Khamira (confections), and oils (Taila).

• Drug Stores: The tradition of “Ghar-e-Dawa” (houses of medicines) marked an early

prototype of pharmacies that stocked, prepared, and dispensed formulations under the supervision of Hakims (Unani physicians). Unani medicine also institutionalized the separation between the prescriber and the Attar (pharmacist/druggist), especially in larger Mughal cities, setting the stage for later pharmacy role differentiation. Cross-Influence and Synthesis India’s multicultural history meant Ayurveda, Siddha, Unani, and local folk systems often exchanged methods an d drugs.

For instance, Unani’s concept of “Mizaj” (temperament) influenced Ayurvedic prakriti, while Siddha methods for mercury processing were adopted in Ayurveda. 2.3 Introduction of Western Medicine (18th–19th Century) The Colonial Context and Healthcare Infrastructure The 18th century marked the establishment of the British East India Company and later direct British Crown rule, bringing drastic changes in health administration. Western medicine began as an adjunct to military strategy; early dispensari es and hospitals catered exclusively to European soldiers and personnel. Gradually, services extended to civilians, missionaries, and privileged local populations.

Importation and Standardization of Medicines At first, all Western medicines were import ed from the United Kingdom or Europe. Bottled tinctures, patent medicines, extracts, and surgical supplies arrived via sea, labeled in English or Latin. Some were repacked or reformulated locally to suit Indian conditions (e.g., climate, palatability).

Birth of the “Compounder” Role Drug preparation and compounding shifted from traditional healers to a new class: the compounder. These assistants—usually Indian men but supervised by British medical officers—were responsible for:

• Compounding prescriptions from raw chemicals and botanicals
• Packaging powders, ointments, and pills
• Preparing tinctures and solutions in apothecaries

However, they typically learned by trial-and-error or informal apprenticeships, without any standardized training curriculum. The line between physicians, compounders, and dispensers remained blurred, especially outside cities and military hospitals. Pharmacy Education—The Early Voids Formal pharmacy education did not exist.

The apprenticeship model led to marked variability in skills and quality, fostering mistakes in dosing and drug mixing. Errors, adverse reactions, and drug misidentification were not uncommon, partly due to the vast diversity of imported and local substances. Unregulated Drug Markets The lack of legal frameworks until the 20th century meant that:

• Quackery flourished: Unlicensed practitioners dispensed dubious products.
• Drug quality fluctuated: Adulteration, mislabeling, and contamination were common

complaints.

• Supervision Gap: District surgeons (British) provided some oversight, but vast

geographies and small budgets left most of India's population dependent on parallel indigenous systems. First Attempts at Regulation and Reform By the late 19th century, alarm at drug-related tragedies (e.g., adulterated quinine, morphine poisoning) and pressure from British public health reforms led to

• Establishment of medical and pharmacy sections at major hospitals (e.g., Calcutta

Medical College, Madras Medical College)

• The first pharmacy apprenticeships being attached to medical colleges
• Early government circulars calling for the creation of “Qualified Compounders”

through standardized courses The Seeds of Change These developments laid the foundation for the recognition that pharmacy is a science and profession in its own right, requiring regulation, formal education, and separation from medical practice—a recognition that would only be institutionalized in the early 20th century. 3. Development of Pharmacy Education in India

3.1Need for Formal Training

At the dawn of the 20th century, pharmacy practice in India was marked by a stark absence of standardized education or qualifications. Most “compounders” learned their trade through informal apprenticeships or ad hoc training in dispensaries, resulting in wide variability in compounding skills, drug measurement, and labeling. This led to frequent dosing errors, inconsistencies in preparation techniques, and challenges with drug quality and patient safety.

The expansion of Western medicine, especially in colonial hospit als and dispensaries, highlighted the limitations of this loose structure. Drug adulteration, confusion in prescription interpretation, and a lack of systematic knowledge on emerging synthetic medicines presented real health risks. At the same time, the ph armaceutical sciences were progressing rapidly in Europe and America, emphasizing the need for chemistry, pharmacology, and therapeutics as core disciplinary pillars.

Indian reformers and British medical officers recognized that for India to advance in pub lic health and pharmaceutical manufacturing, a systematized education and regulation of pharmacy was required. Seeded by medical tragedies, medical council reports, and the drive for “indigenous” development during the Indian freedom movement, calls grew louder for organized degree and diploma programs, standardized syllabi, and national examination and registration of practitioners. The goal was not merely to train “compounders”, but to establish pharmacy as a distinct and respected healthcare science bridging chemistry, biology, and clinical medicine.

Key Catalysts for Reform

• Increasing complexity of medicines (from botanicals to synthetics)
• Growth in pharmaceutical manufacturing and drug imports after World War I
• Dosing and formulation errors in hospitals and community pharmacies
• Pressure to align with global developments in pharmacy and higher education

3.2 Early Institutions: Foundational Pillars The initiative for formal pharmacy education in India was led primarily by major universities in the ear lier half of the 20th century. These efforts laid the cornerstone of a profession al pharmaceutical workforce. 1932: Department of Pharmaceuticals, Banaras Hindu University (BHU) BHU was the first in India to recognize pharmacy as an academic discipline , establishing a dedicated Department of Pharmaceuticals under the visionary leadership of Professor M. L.

Schroff. In 1932, BHU launched the nation’s firstdegree course in pharmacy, based on international standards but adapted for Indian needs. The BHU curriculum included:

• Pharmaceutical Chemistry
• Pharmacognosy (study of medicinal plants)
• Pharmacology and Human Physiology
• Pharmacy Practice (compounding, dispensing, and drug formulation)
• Practical training in hospital dispensaries and industry

This pioneering syllabus became a template, influencing other institutions. 1935: University of Bombay In 1935, the University of Bombay introduced the Bachelor of Pharmacy (B.Pharm) program, signaling the beginning of pharmacy as a standalone academic pursuit in weste rn India. The program was designed to train students in all aspects of modern pharmaceutical sciences — formulation, quality assurance, toxicology, and regulatory procedures. The University of Bombay’s involvement gave further legitimacy and momentum, promot ing the idea that pharmacists could—and should—be healthcare specialists on par with doctors and nurses. 1944: Bengal Pharmacist Registration Act Recognizing the need for practitioner accountability, Bengal (now West Bengal) introduced India’s first regional law for pharmacist registration.

The legislation mandated the registration of qualified pharmacists to practice in the province, laying the groundwork for a future nation-wide system. This step mirrored similar regulatory efforts in Western countries and signaled a growing awareness of the pharmacist's public health role.

Year Institution/Act Contribution 1932 Banaras Hindu University First Indian Pharmacy Degree course 1935 University of Bombay B.Pharm program launched 1944 Bengal Pharmacist Registration Act Formal regional pharmacist registration 3.3 The Pharmacy Act of 1948: Foundation of Modern Pharmacy Practice The conclusion of World War II and the advent of India’s independence led to a renewed focus on public health and education. The “Pharmacy Act, 1948” became a watershed moment, transforming pharmacy from a loosely regulated trade to a recognized profession governed by national law. This landmark legislation accomplished several enduring objectives: Establishment of the Pharmacy Council of India (PCI)

• The Pharmacy Council of India was formed as a central statutory body to regulate the

education and profession of pharmacy nationwide.

• PCI’s responsibilities included setting minimu m educational standards, approving

curricula, inspecting institutions, and maintaining professional ethics. Standardization of Curriculum

• The Act introduced uniform courses at diploma (D.Pharm) and degree (B.Pharm)

levels, ensuring all students learned cor e sciences (chemistry, biology, pharmacology, pharmacy practice, and drug legislation).

• Emphasis was placed on laboratory training, clinical exposure, and pharmaceutical

calculations for safe medicine preparation and dispensing. Creation of State Pharmacy Councils

• Each state was mandated to create its own pharmacy council, which would manage

local registration, verification of credentials, and upkeep of pharmacist databases. Compulsory Registration

• The Act made it illegal to practice as a pharmacist or compounder without valid

registration—a major step in protecting patients from unqualified practitioners. Code of Ethics and Professional Conduct

• Guidance was issued regarding patient interaction, record keeping, and responsibility

for drug safety. Impact Analysis

• Elevated the status of pharmacists in society and the healthcare system.
• Improved quality control and public confidence in drug dispensing.
• Created a uniform regulatory structure, facilitating research, mobility, and global

recognition. Excerpt from the Act "No person other than a registered pharmacist shall compound, prepare, mix or dispense any medicine on the prescription of a medical practitioner..." 3.4 Expansion and Modernization: From Post-independence to the Present Day Role of AICTE (1945 Onwards) Shortly before independence, the All India Council for Technical Education (AICTE) was established to oversee and coordinate technical education, including pharmacy. The AICTE played an instrumental role in:

• Accrediting institutions and enforcing national educational standards.
• Supporting the establishment of new colleges across the country, especially in

underserved regions.

• Promoting curriculum modernization, pedagogical advances, and university -industry

collaboration. As a result, pharmacy education became more accessible, with diploma and degree programs proliferating in every state. NIPER Institutes: Elevating Research and Postgraduate Education Recognizing the need for world -class pharmaceutical research, the Government of India founded the National Institute of Pharmaceutical Education and Research (NIPER) in 1998 in Mohali (Punjab).

This was later expanded with multiple campuses nationwide.

• NIPERs focus on postgraduate (M.Pharm, PhD) and research training—drug discovery,

nanotechnology, pharmacoinformatics, regulatory science, and clinical research.

• NIPERs actively collaborate with the pharmaceutical industry and international

agencies.

• These institutes have played a pivotal role in cementing India’s reputation as a global

leader in generics, vaccines, and pharmaceutical innovation. Introduction of Pharm.D (Doctor of Pharmacy) (2008)[29] Responding to global trends and the need for clinical pharmacy expertise, the Doctor of Pharmacy (Pharm.D) program was introduced in 2008.

• The six-year Pharm.D curriculum focuses on clinical pharmacy, therapeutics, hospital

practice, and direct patient care.

• Students receive sustained clinical training in hospitals, with rotations in medicine,

surgery, and specialized care units.

• Pharm.D graduates are regarded as medication experts—managing dosages, preventing

drug interactions, counseling patients, and participating in clinical teams. This marks a shift of the Indian pharmacist’s role from factory and retail work to clinical, patient-centric practice, aligning Indian education with healthcare models in th e US, Europe, and Australia. Contemporary Developments and Challenges

• Growth: Hundreds of public and private colleges now offer D.Pharm, B.Pharm,

M.Pharm, and Pharm.D degrees, alongside vocational and certificate courses.

• Challenges: Ensuring quality amidst the proliferation of private institutions, updating

curricula for biotechnology and personalized medicine, and integrating ethics, soft skills, and research capacity.

• Internationalization: Indian pharmacy degrees are increasingly recognized worldwide,

enabling students to study and work abroad.

Year Event/Institution Significance 1948 Pharmacy Act PCI, registration, standards 1945 AICTE Quality assurance, expansion 1998 NIPER Institutes Research/postgraduate education 2008 Pharm.D program Clinical pharmacy era

3.5Pharmacy Education as Nation Building

The journey of pharmacy education in India reflects the interplay of necessity, vision , policy, and scientific progress. By moving from an unregulated apprenticeship -based model to a robust, multi -tiered educational system, India has not only improved public health and pharmaceutical safety but also positioned itself as a formidable player in the global pharmaceutical arena. As India looks ahead, challenges of standardization, modernization, research integration, and international collaboration remain central, but the foundation laid over the past century offers a strong platform for progress and innovation. 4.

Growth of Pharmaceutical Industry in India

4.1Early Dependence on Imported Medicines

Prior to independence, India’s pharmaceutical landscape was characterized by a heavy reliance on imported finished formulations and raw materials . Colonial priorities led to a healthcare system centered on Western medicine for administrative and military needs, with limited local manufacturing capacity. A few small -scale apothecaries and compounding units existed in major urban centers (Calcutta, Bombay, Madras), primarily repackaging imported bulk drugs or producing simple formulations such as tinctures, ointments, and powders.

Indigenous systems (Ayurveda, Siddha, Unani) continued to thrive, but a modern chemical-pharmaceutical manufacturing base remained minimal. Key constraints that maintained import dependence:

• Limited chemical industry backbone: Insufficient local production of active

pharmaceutical ingredients (APIs) and intermediates.

• Absence of product development capabilities: Very few institutions with expertise in

modern dosage form design, stability testing, and scale-up.

• Lack of formal regulation and quality standards: Until mid-20th century reforms, drug

quality could vary widely.

• Capital and technology barriers: Limited access to process know-how, equipment, and

foreign capital.

• Market dominance by multinationals: European and British firms controlled major

product pipelines and distribution. By the 1930s –40s, emerging nationalist and scientific leaders advocated for self -reliance in medicines, especially anti-infectives, vitamins, and essential drugs. This vision set the stage for state-backed industrial initiatives after independence.

4.2Key Milestones

Post-independence policy deliberately fused public-sector investment, patent reform, and scientific institution-building to create an indigenous pharma backbone. The following milestones were pivotal:

• Hindustan Antibiotics Ltd. (HAL), 1954 — First large-scale antibiotic production
• Established at Pimpri, Pune, with WHO and UNICEF support, HAL became

India’s first major public-sector pharma facility.

• It enabled domestic production of penicillin and later other antibiotics,

reducing reliance on costly imports and expanding access to life-saving anti- infectives.

• HAL catalyzed skill development in fermentation technology, quality control,

and sterile manufacturing—capabilities that seeded broader industrial competencies.

• Indian Drugs and Pharmaceuticals Ltd. (IDPL), 1961 — Reduced drug imports.
• IDPL was created to produce bulk drugs and essential formulations at scale,

often in therapeutic categories underserved by private firms due to low margins.

• It diversified India’s capability set to include APIs, hormones, vitamins, and

anti-TB drugs, thereby stabilizing supply and prices.

• IDPL’s plants and training ecosystems developed a cadre of engineers,

chemists, and pharmacists who later permeated the private sector.

• Indian Patents Act, 1970 — Enabled generics; reduced costs
• The Act shifted India from product patents to process patents, allowing

domestic firms to legally develop alternative manufacturing routes to patented molecules.

• This triggered the rise of India’s generics industry—companies reverse-

engineered drugs, optimized processes, and produced at significantly lower costs.

• Result: Dramatic price reductions in essential medicines, growth in domestic

availability, and the emergence of Indian firms as competitive exporters over the next two decades.

• Economic Liberalization, 1991 — Competition and export-led growth[35]
• Liberalization reduced barriers to imports of equipment and technology,

opened capital markets, and encouraged joint ventures and exports.

• Indian firms upgraded quality systems, adopted international Good

Manufacturing Practices (GMP), and aimed for US FDA and EMA approvals.

• This period saw scale-up in APIs and formulations, as well as the initial move

into regulated markets with dossiers, bioequivalence studies, and compliance infrastructures.

• TRIPS Compliance (2005) — Product patents and innovation push
• With WTO-TRIPS compliance, India re-introduced product patents, altering

the competitive game for new molecules.

• Firms intensified investment in R&D, complex generics, biosimilars, novel

delivery systems, and niche therapeutic segments.

• This shift also accelerated strategic pivots: partnerships for innovation,

contract research and manufacturing services (CRAMS/CDMO), and a sharper focus on intellectual property management. Suggested compact table for the chapter layout: Milestone | Impact[37]

• HAL, 1954 | Built indigenous capacity in antibiotics; reduced imports; developed

fermentation expertise

• IDPL, 1961 | Expanded bulk drug and essential medicine production; trained technical

workforce

• Patents Act, 1970 | Enabled process-patent era; rapid growth of generics; major cost

reductions

• Liberalization, 1991 | Technology access, quality upgrades, global filings; export

acceleration

• TRIPS, 2005 | Product patents restored; push toward innovation, complex generics,

biosimilars 4.3 Current Status[38] India today is globally recognized as the “Pharmacy of the World,” a status earned through scale, affordability, and compliance with stringent regulatory regimes. The industry’s capabilities span the entire value chain: API synthesis, formulations, vaccines, diagnostics adjuncts, and contract services. Core pillars of India’s current pharmaceutical strength:

• Largest supplier of generics
• Indian companies supply a significant share of generic medications used

worldwide, especially in the United States, Europe, Africa, and Latin America.

• Therapeutic breadth includes anti-infectives, cardiovascular, diabetes,

oncology, neurology, and more.

• Strong dossier development, bioequivalence studies, and regulatory filings

underpin this leadership.

• Vaccine leadership, including COVID-19
• India is one of the world’s largest producers of vaccines by volume.
• During COVID-19, Indian manufacturers supplied vaccines domestically and

internationally, reinforcing the nation’s role in global public health.

• Long-standing expertise in polio, measles, DTP, and other vaccines supports

routine immunization worldwide.

• Exports to 200+ countries
• Indian pharma exports span regulated and semi-regulated markets, including

APIs and finished dosage forms.

• A strong presence in antiretrovirals and anti-malarials has been crucial for

global disease control initiatives. Emerging Trends and Strategic Shifts[38]

• Complex generics and specialty products: Sustained focus on modified-release

formulations, inhalation products, transdermals, ophthalmics, and injectables.

• Biosimilars and biologics: Growing capabilities in monoclonal antibodies, insulin

analogs, and other biologics—requiring advanced analytical characterization and comparability studies.

• Digital and data-driven R&D: Use of computational chemistry, AI-assisted screening,

and real-world evidence to optimize pipelines and pharmacovigilance.

• Regulatory maturity: Increasing WHO prequalification, US FDA/EMA-approved

sites, and alignment with ICH guidelines have enhanced credibility.

• CRAMS/CDMO growth: India is a preferred global hub for contract research,

development, and manufacturing, leveraging cost efficiencies and scientific talent.

• Quality and compliance focus: Continuous investment in data integrity, serialization,

supply chain traceability, and remediation programs to meet evolving regulatory expectations. Challenges and Opportunities Ahead[39]

• Quality harmonization: Ensuring consistent GMP compliance across thousands of

facilities, particularly SMEs.

• Innovation funding: Balancing high-volume generics with riskier innovation

(NCEs/NBEs) and high-cost biologics programs.

• Skilled workforce: Ongoing need for upskilling in sterile operations, regulatory

science, data integrity, and advanced analytics.

• Global supply chain resilience: Diversifying raw material sources, investing in

domestic KSMs/intermediates, and strengthening API independence. 5. Role of Professional and Regulatory Organizations

Organization Role Pharmacy Council of India (PCI) Regulates pharmacy education and registration Drug Controller General of India (DCGI) Approves new drugs and regulates clinical trials Central Drugs Standard Control Organization (CDSCO) Ensures drug quality and safety Indian Pharmaceutical Association (IPA) Professional body promoting pharmacy practice FIP (International) Global collaboration to advance pharmacy The progress, credibility, and structure of pharmacy and pharmaceuticals in India owe much to the vigilant work of professional bodies and regulatory authorities. By establishing standards, defending public health, promoting education, and advocating professional interests, these organizations have played pivotal roles in shaping the evolution of pharmacy from both a technical and an ethical perspective.

5.1Pharmacy Council of India (PCI)

Established under the Pharmacy Act of 1948, the Pharmacy Council of India (PCI) is the apex regulatory authority overseeing pharmacy education and the profession in India [40]. Core Functions:

• Defining minimum standards for pharmacy education (D.Pharm, B.Pharm, M.Pharm,

Pharm.D).

• Approving and inspecting institutions—ensuring infrastructure, faculty, and curricula

meet national norms.

• Maintaining the Central Register of Pharmacists, and guiding state councils.
• Laying down a Code of Ethics for pharmacists, promoting patient safety, and

responsibility.

• Advising government policy on issues of registration, practice, and new pharmacy

roles. The PCI has been instrumental in standardizing pharmacy education, enabling nationwide mobility for pharmacists, safeguarding professional integrity, and encouraging the integration of pharmacists into multidisciplinary healthcare teams.

5.2State Pharmacy Councils

Every state and union territory has its own State Pharmacy Council under the guidance of PCI. Key Roles:

• Registering qualified pharmacists and updating state rolls.
• Conducting periodic renewals, and verifying the credentials of pharmacy

practitioners.

• Addressing complaints of malpractice and ethics violations.
• Organizing continuing education workshops to ensure professional development.

These councils serve as direct points of engagement for pharmacists, ensuring local accountability and regional policy adaptation, such as language needs, public health priorities, and state-specific challenges.

5.3Central Drugs Standard Control Organization (CDSCO)

The national regulatory authority for drugs and medical devices in India, CDSCO operates under the Directorate General of Health Services, Ministry of Health & Family Welfare. Principal Functions:

• Licensing and quality control of new drugs, vaccines, blood products, and medical

devices.

• Granting approvals for clinical trials, import/export of pharmaceuticals, and setting

quality benchmarks.

• Coordinating with the World Health Organization (WHO), US FDA, EMA, and other

regulatory agencies worldwide for global harmonization.

• Conducting Good Manufacturing Practice (GMP) inspections and pharmacovigilance

programs.

• Framing and updating the Drugs & Cosmetics Act and Rules, which serve as the

foundation for all drug regulation in India. CDSCO ensures that medicines and medical devices in Indian markets are safe, effective, and of international quality. It is vital for global pharma exports, facilitating approvals and audits for regulated markets.

5.4Drug Regulatory and Licensing Authorities at the State Level

Each state maintains State Drug Control Organizations, which:

• Execute the Drugs & Cosmetics Act at the grassroots level, ensuring retailers,

wholesalers, and manufacturers comply with licensing and inspection requirements.

• Monitor and sample drug quality, investigate adulterated/counterfeit medicines, and

issue penalties or prosecutions.

• Conduct awareness campaigns regarding rational drug use, antimicrobial resistance,

and patient rights. These authorities are the first responders in public health emergencies related to drugs, recalling substandard batches and prosecuting offenders. 5.5 Professional Bodies: Indian Pharmaceutical Association (IPA) and Others Professional organizations play a complementary role by advocating for pharmacy professionals, advancing science, and building community. Indian Pharmaceutical Association (IPA):

• Founded in 1939, IPA is the largest national professional body for pharmacists—

practitioners, educators, scientists, and students.

• Organizes annual conferences, publishes the Indian Journal of Pharmaceutical

Sciences, and represents India at global forums (FIP, WHO).

• Promotes pharmacy practice reform, continuing education, community pharmacy, and

ethical standards. Other Key Bodies:

• Indian Hospital Pharmacists Association (IHPA): Focuses on hospital pharmacy

practice, therapy management, and patient safety.

• Association of Pharmaceutical Teachers of India (APTI): Champions pharmacy

education and faculty development.

• Indian Pharmacy Graduates Association (IPGA): Facilitates networking, skill

development, and research dissemination.

• Pharmacy Council of India Alumni Associations: Build alumni engagement for

mentoring and knowledge exchange. These organizations cultivate a sense of professional identity, foster lifelong learning, connect academia with industry, and provide platforms for policy dialogue and research.

5.6International Engagement and Harmonization

In the pharmacy industry, Indian professional and regulatory organisations are becoming more and mor e significant players in global participation and harmonisation. They are working together, taking the lead, and influencing international pharmaceutical standards in a number of ways that go far beyond basic participation:

• Global Memberships and Participation: India actively participates in and contributes

to a number of prestigious international organisations, such as the World Health Organisation (WHO) regulatory programs, the International Council for Harmonisation (ICH), and the International Pharmaceu tical Federation (FIP). Indian delegates frequently participate in debates, working groups, and decision -making forums concerning international drug safety, laws, and pharmacy procedures.

• Collaboration with Leading Authorities: India maintains close ties with international

regulators such as the US FDA, UK MHRA, and EMA. These partnerships improve the acceptance and credibility of Indian medicines worldwide by facilitating the sharing of best practices, inspection protocols, data interchange, and co -development of guidelines.

• Development and Harmonization of Guidelines:

India actively participates in the development and implementation of guidelines for Good Pharmacy Practice (GPP), Good Manufacturing Practice (GMP), and Good Clinical Practice (GCP). India g uarantees that its pharmaceutical processes — manufacturing, clinical trials, and dispensing —meet top -notch quality and safety requirements by implementing ICH and WHO guidelines. To align pharmacopeial standards, inspection procedures, and regulatory docum entation with global norms, Indian agencies, such as the Central Drugs Standard Control Organisation (CDSCO) and Indian Pharmacopoeia Commission (IPC), start evaluations and changes.

Indian regulators also participate in working groups that oversee clinica l research requirements, excipient supply chains, standards for active pharmaceutical ingredients (APIs), and the worldwide harmonisation of pharmacopoeias. Capacity Building and Training: Recognizing the need for strong regulatory capabilities, India has rolled out training and capacity -building programs in association with international agencies, empowering professionals to implement GCP, GMP, and GPP guidelines effectively. Promoting International Convergence: In order to ensure that standards promote equitable, effective pharmaceutical commerce and improve public health, India organises international summits and takes part in committees devoted to regulatory convergence.

Impact: These initiatives strengthen India's position as the "Pharmacy of the World, " enable Indian pharmaceutical companies and goods to compete internationally, and expedite regulatory approvals in foreign markets. Harmonisation increases productivity, cuts down on unnecessary testing, enhances medication quality, and guarantees millions of people throughout the world safer healthcare. India is currently a global leader in regulatory science and harmonisation as a result of its involvement, which not only influences domestic practices and education but also raises pharmaceutical standard s worldwide.

Conclusion: The development of the pharmacy profession in India is a reflection of the country's overall advancements in science, healthcare, and education. The profession has experienced tremendous change from old medical systems to the creation of formal pharmacy education and regulatory frameworks. Pharmacists' identities and social roles have been reinforced by the expansion of pharmaceutical enterprises, improvements in medication manufacture and research, and the establishment of professional associations.

Pharmacists are now acknowledged as vital healthcare workers participating in patient counselling, clinical services, regulatory affairs, drug discovery, and public health activities, in addition to being recognised as distributors of medications. Their contribution to healthcare delivery is further enhanced by ongoing changes in pharmacy education, such as competency-based curricula and an emphasis on practical training. The pharmacy profession is well-positioned to play a crucial role in guaranteeing the community receives safe, moral, and high-quality healthcare as India's pharmaceutical industry continues to grow and develop.

References: 1. Basak, S. C.

(2010). Pharmacy education in India . Journal of Pharmacy and Bioallied Sciences.

Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2879119/ 2. Pharmacy Council of India. (n.d.).

Introduction to the Pharmacy Act, 1948. Pharmacy Council of India. Retrieved https://www.pci.nic.in/GenInfo_About_Introduction.html 3.

Government of India. (1940). Drugs and Cosmetics Act, 1940 (and Rules, 1945).

Ministry of Health and Family Welfare. Retrieved from https://cdsco.gov.in/ and related government publications. 4. Government of India.

(1948). The Pharmacy Act, 1948 . (Pharmacy Act text).

Retrieved from https://www.indiacode.nic.in/bitstream/123456789/6838/1/pharmacy_act_1948.pdf 5. Central Drugs Standard Control Organization (CDSCO). (n.d.).

About CDSCO. CDSCO, Ministry of Health & Family Welfare. Retrieved from https://cdsco.gov.in/ 6.

National Pharmace utical Pricing Authority (NPPA). (n.d.). About NPPA .

Department of Pharmaceuticals, Government of India. Retrieved from https://nppa.gov.in/ 7. World Health Organization; International Phar maceutical Federation (FIP).

(2011). Joint FIP/WHO guidelines on good pharmacy practice: Standards for quality of pharmacy services (Annex 8). WHO.

Retrieved from https://www.who.int/docs/default-source/medicines/norms-and- standards/guidelines/distribution/trs961-annex8-fipwhoguidelinesgoodpharmacypractice.pdf 8. FIP (International Pharmaceutical Federation). (2011).

Quality assurance of pharmacy education: A global framework . FIP. Retrieved from https://www.fip.org/files/fip/PharmacyEducation/Quality_Assurance/QA_Framework_2nd_Edition_on line_version.pdf 9.

Sood, M. A. (2019).

Evolution of Indian pharmaceutical industry – overview. Unnayan: International Bulletin of Management and Economics, Special Issue. Retrieved from institutional repository. 10.

Nishith Desai Associates. (2024). The Indian Pharmaceutical Industry: Regulatory and commercial overview.

Nishith Desai Research. Retrieved from https://www.nishithdesai.com/fileadmin/user_upload/pdfs/Research_Papers/The -Indian- Pharmaceutical-Industry.pdf 11. ResearchGate.

(2024). Indian pharmaceutical industry: Past, present and future outlook (2024 –2030). ResearchGate.

Retrieved from https://www.researchgate.net/ 12. Kapoor, P., & Sharma, R. (2021).

Literature review on pharmaceutical industry in India: Evolution and current trends. IJSRET, 7(1). Retrieved from https://ijsret.com/ 13.

Pharmascholars. (2018). Implementation of Drugs and Cosmetics Act, 1940 and Rules among the southern states of India.

Pharmascholars Journal. Retrieved from https://www.pharmascholars.com/ 14. Ipleaders Blog.

(2022). The Drugs and Cosmetics Act, 1940: An overview . iPleaders. Retrieved from https://blog.ipleaders.in/drugs-and-cosmetics-act-1940/ 15.

Government of India — Department of Pharmaceuticals. (n.d.). Departmental policies and reports .

Ministry of Chemicals & Fertilizers. Retrieved from https://pharma-dept.gov.in/ 16. Abjar & Vandana Publications.

(2023). Decoding the evolution of the Indian pharmaceutical industry . Journal article.

Retrieved from publisher site. 17. CBSPD/teaching material. (2025).

History of Pharmacy Profession in India (teaching notes). Retrieved from CBSPD repository. 18. Montu Patel / PCI news coverage.

(2025). Reports on governance and investigations related to the Pharmacy Council of India. The Times of India.

Retrieved from https://timesofindia.indiatimes.com/ 19. Times of India. (2025).

No admissions to 89 pharmacy colleges over norm violations . News article. Retrieved from https://timesofindia.indiatimes.com/ 20.

Atkinson, J. (2011). The PHARMINE report on pharmacy education and practice (EU overview).

Pharmacy Practice. Retrieved from https://www.pharmacypractice.org/ 21. Indian Pharmaceutical Association (IPA).

(n.d.). History and role of the IPA . Indian Pharmaceutical Association official materials.

Retrieved from IPA website. 22. Bengal Chemical and Pharmaceutical Works historical accounts (Prafulla Chandra Ray). (n.d.).

History of early pharmaceutical manufacturing in India. Retrieved from historical sources and company records. 23. Acharya, P.

C. (historical analyses). (n.d.).

Contributions of Prafulla Chandra R ay to Indian pharmacy and chemistry. Journal and historical archives. 24. Implementation studies — regional (Southern states).

(2017). State-level interpretations of Drugs and Cosmetics Act enforcement. Regional pharmaco-regulatory studies. 25.

Cosmetics Rules, Go vernment of India. (2020). Cosmetics Rules, 2020 (Amendments and regulatory evolution).

Ministry of Health and Family Welfare / CDSCO. Retrieved from official gazette and government portals. 26. Journal of Indian Medical Research / ICMR reports.

(various years ). Pharmaceutical research, occupational training and regulation in India. Indian Council of Medical Research publications. 27.

Patent Law amendments — Government of India (2005). Amendments to the Patents Act, 1970 — effect on pharmaceuticals and generic drug industry. Government of India publications and analyses. 28.

World Trade Organization / TRIPS materials. (2005). TRIPS, pharmaceuticals and Indian patent regime: Analysis of amendment impact.

WTO documentation and policy analyses. 29. Economic Times (healthcare s ection). (2025).

CDSCO alerts and regulatory news —drug safety events in India. The Economic Times. Retrieved from https://economictimes.indiatimes.com/ 30.

Reuters Health. (2025, Oct). WHO warns of contaminated India cough syrups (news advisory).

Reuters. Retrieved from https://www.reuters.com/ 31. IKPR Press / Journal analyses.

(2024). The impact of India's Drugs and Cosmetics Act relating to public health and enforcement. Journal of International Res earch in Medical & Public Health.

Retrieved from ikprress.org. 32. DDRegPharma / drug regulation educational pages. (n.d.).

Historical background of the Central Drugs Standard Control Organization (CDSCO). Retrieved from https://www.ddregpharma.com/ 33. PhD / academic theses.

(Various). Historical evolution of pharmacy education in Indian universities (case studies: BHU, Bombay, Madras, Calcutta). University repositories. 34.

Slideshare / teaching slides. (n.d.). History and development of pharmacy in India (lecture slides).

Retrieved from https://www.slideshare.net/ 35. Scribd / educational chapter. (n.d.).

Pharmaceutics – Chapter 1: History of the Profession of Pha rmacy in India in relation to pharmacy education, industry and practice . Retrieved from https://www.scribd.com/ 36. Journal of Pharmaceutical Policy and Practice.

(various). Regulation, accreditation and pharma cy education quality in India. Peer-reviewed articles. 37.

Drug Control Administration (State DCA) reports and case studies. (2025). Enforcement actions and prosecutions under the Drugs and Cosmetics Act — state-level reports.

State DCA publications and press releases. 38. National Institute of Pharmaceutical Education and Research (NIPER). (n.d.).

NIPER history, role and contributions to pharmaceutical education and research in India. Retrieved from NIPER official websites. 39. World Health Organization.

(n.d.). Norms and standards for pharmaceuticals: Guidance and regulatory frameworks. WHO website.

Retrieved from https://www.who.int/teams/health-product-and-policy- standards/standards-and-specifications/norms-and-standards-for-pharmaceuticals/guidelines 40. Policy briefs and white papers (industry and legal firms). (2023 –2025).

Analyses of the pharmaceutical regulatory environment in India (pricing, quality, and education oversight). Representative example: law firm white papers (e.g., Nishith Desai), think-tank reports, and government consultation documents.